Your SlideShare is downloading. ×
Utilizing Social Media for New Product Launch
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Utilizing Social Media for New Product Launch

1,148
views

Published on

Presentation at Canadian emarketing conf. Nov 2011 (ddelong@cmg-pharma.com)

Presentation at Canadian emarketing conf. Nov 2011 (ddelong@cmg-pharma.com)

Published in: Business, Technology

0 Comments
4 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,148
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
4
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Worse than no-see rate
  • Strategic listening.
  • Products thathave failed9/10products have same positioning
  • Confirm Forecast = Lilkihood to RxModel the Market – as changes occur in promotinal dynamicsConfirm Revenue ForecastProduct Positioning – offensive/flanking or Guerilla (9/10 products same positining)Pre-launch Promotion – Move docs thrugh first
  • What do I need a rep forI know the studiesI don’t want biased informationApplication to my clinical situation
  • Confirm Forecast = Lilkihood to Rx
  • Metrics such as: Visits Unique commenters Time on Site Network size / quality Quantity / Quality of Commentary Thread size (how invested members are) Time with content (people reading or interacting with the content might be very interested, but quiet)Versus Reach / Frequency / Share of Voice
  • Lots of information sources vying for physician`s attention
  • comparable to Pfizer’s Geodon and Bristol-Myers’ Abilify, that is, less than Lilly’s ZyprexaAnd, unlike some other atypicals, Meltzer says that Latuda dosages donot require a lot of titration. “If you have an acutely ill patient, you can start them at 40 [mg] andit’s going to start to work within days, if not hours, based, of course, on how ill the patient is. Youdon’t have to experiment [with the dose] as you do with, say, quetiapine, where it is difficult to
  • Engagement
  • Research Lead = Engagment – Quanity and QualityDiscussion – Pharma and PhysiciansPeceotion is out of sync with medical factBenchmarking = JD Power rankingSaving Physician time
  • Strategic listening
  • What % see non-adherence as a clinical problemHow big a clinical problemPerception of clinical impactWhat % of patients affectedPerception of the role of weight gain
  • Decide if they will a product to their armamentarium
  • Scientifically validatedWillhappenwether you partiicpate of not.
  • Transcript

    • 1. UtilizingSocial MediaforNew Product Commercialization 1
    • 2. Who Are We? 2
    • 3. Today We’ll Discuss  Presentation Context  Pharma & Social Media  Why Social media should be on Your Radar Screen for New Product Commercialization  Demonstrate the Tactical Role of Social Media in New Product Commercialization
    • 4. Background 4
    • 5. Background 5
    • 6. Background 6
    • 7. Background The Physician still has to prescribe it! 7
    • 8. Pharma & Social Media Primary Target for Digital CommunicationAcross Health Digital Survey EMEA 2011 8
    • 9. Pharma & Social MediaSocial Media and Healthcare, EPG Health Media, Summer 2011 9
    • 10. Pharma & Social Media % Utilization of Digital ToolsAcross Health Digital Survey EMEA 2011 10
    • 11. Pharma & Social Media Physicians Don’t Want to Talk to You 100 Influence % online HCPs 80 Consulting with Colleagues in Person Offline Journals Online Journals HCPs-only Portal (Social Networks) 60 40 20 Sales Reps Pharma Websites 20 40 60 80 100 Weekly/Daily Use % online HCPs 11
    • 12. Pharma & Social Media Toronto Diabetes KOL Network Physicians are already organized into communities and are actively engaged in conversationsSource: Lnx Pharma 12
    • 13. Pharma & Social Media Re-invent the wheel Work with existing interpersonal communication network 13
    • 14. Pharma & Social Media: Success Factors Talking Listening Push Pull Product Brand Range Brand Selling Pills Outcomes Initiating Participating 14
    • 15. Definition 15
    • 16. Definition – What is Social Media? Social media is the term commonly given to Internet and mobile-based channels and tools that allow users to interact with each other and share opinions and content. As the name implies, social media involves the building of communities or networks and encouraging participation and engagement. 16
    • 17. Why Should Social Media be on the Radar Screen? Difficult Cases Experience with New MedicationsPhysician Participation in Peer-to-Peer Social Media Sites - Why Is It Less Than Expected? 17Pharma Marketing Oct 12 2011
    • 18. Why Should Social Media be on the Radar Screen?Pre-launch Improve the quality of the market research 18
    • 19. Social Media: Impact Pre-Launch  Customer segment research - Clinical Value Criteria  Model the Market  Confirm Revenue Forecast  Product Positioning  Pre-launch Promotion 19
    • 20. Why Should Social Media be on the Radar Screen?Post launchMitigate the rapidlydecreasing effectivenessof the Sales Rep channel.Physician EngagementProduct Diffusion 20
    • 21. Social Media: Impact Post Launch  Increase Reach and Frequency  Contract the Sales Cycle  Increase Speed of Diffusion  Enhance the Clinical / Brand Relevancy  Manage the Physician Experience Trial  Capture Real-time Campaign Management Data 21
    • 22. Hypothetical Case Study Schizophrenia 22
    • 23. Hyper-competition Generic Atypicals 4 23
    • 24. Hyper-competition Branded Atypicals 2 24
    • 25. Hyper-competition Generic Typicals 5 25
    • 26. Hyper-competition Immediate Future 3 26
    • 27. Social Media Strategy: Product Launch Engagement Getting involved and returningInfluence Early Adopters on Early and late Majority 27
    • 28. Something to Talk About!Something to talk about 28
    • 29. Something to Talk About 29
    • 30. Performance on the 4 Pillars of Positioning Efficacy Equal Safety Equal Tolerability Advantage Price Disadvantage 30
    • 31. Opportunity Treatment Failure Rate up to 75% 31
    • 32. Why Psychiatrists Prescribe High Importance Medium Importance 32
    • 33. APPLICATION of SOCIAL MEDIA 33
    • 34. Pre-launch: Customer Research Traditional Market Research Inadequate for Hyper-competition 34
    • 35. Pre-launch: Customer Research  Serial market research participants  All brands have access to the same data  “35,000 foot” view of market – not actionable  9/10 product launch with category leader positioning 35
    • 36. Pre-launch: Customer Research  Switch from a COMMERCIAL to an ACADEMIC research model  Engage the Community in a discussion about the Clinical Value of currently available products 36
    • 37. Pre-launch: Customer Research How do I impact prescribing behaviour? I know What I don’t know Is Rx’d Why it is Rx’d (The Behaviour) @ Customer Segment (The Motivation) 37
    • 38. Pre-launch: Customer Research Clinical Value Analysis Research Lead Deliverable to Deliverable to Physicians Pharma Benchmarking Data Segment Level Data Present Findings & Facilitate Discussion / Debate 38
    • 39. 39
    • 40. Pre-launch: Pre-launch Promotion Alternative to... 40
    • 41. Pre-launch: Pre-launch Promotion Position in Practice Capture Trial Criteria Get Trial Ensure Trial Success Review Review Options Trial Progress Define the Clinical Problem 41
    • 42. Pre-launch: Pre-launch Promotion  Initiate a discussion about the role of weight gain in treatment non-adherence.  Employ Clinical Value Analysis to review the failings of available drugs to solve the clinical problem 42
    • 43. Introducing asolution to What problemschizophreniatreatment do you solve?non-adherence 43
    • 44. Pre-launch: Pre-launch Promotion  Move physicians through the early stages of adoption – missionary work  Launch into Experience Trial phase - Rxs  Gain access to No-see / Limited-see physicians  Data to refine launch strategy  Discover points of competitive entry 44
    • 45. Post-launch: Manage the Experience Trial A model that describes how physicians adopt new treatment options 45
    • 46. Post-launch: Manage the Experience Trial Position in Practice Capture Trial Criteria Get Trial Ensure Trial Success Review Review Options Trial Progress Define the Clinical Problem 46
    • 47. Post-launch: Manage the Experience Trial Self expression Communication Sharing Collaboration 47
    • 48. Post-launch: Manage the Experience Trial  Supplement Rep Activity  Reach access challenged physicians  Manage the most important phase of the product lifecycle  Acquire forward looking data 48
    • 49. Pharma & Social Media 49